Fortress Biotech Stock Piotroski F Score

FBIO Stock  USD 1.97  0.01  0.51%   
This module uses fundamental data of Fortress Biotech to approximate its Piotroski F score. Fortress Biotech F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Fortress Biotech. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Fortress Biotech financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Fortress Biotech Altman Z Score, Fortress Biotech Correlation, Fortress Biotech Valuation, as well as analyze Fortress Biotech Alpha and Beta and Fortress Biotech Hype Analysis.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.
  
At this time, Fortress Biotech's Net Debt is very stable compared to the past year. As of the 12th of June 2024, Long Term Debt Total is likely to grow to about 99.5 M, while Long Term Debt is likely to drop about 42.4 M. At this time, Fortress Biotech's Dividend Yield is very stable compared to the past year. As of the 12th of June 2024, Days Sales Outstanding is likely to grow to 132.42, while Price To Sales Ratio is likely to drop 0.27.
At this time, it appears that Fortress Biotech's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Decreasing

Focus
Asset Turnover Growth

Increase

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Decrease

Focus
Change in Gross Margin

No Change

Focus

Fortress Biotech Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Fortress Biotech is to make sure Fortress is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Fortress Biotech's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Fortress Biotech's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.530.5045
Sufficiently Up
Slightly volatile
Gross Profit Margin0.440.6582
Way Down
Slightly volatile
Total Current Liabilities46.5 M84.9 M
Way Down
Slightly volatile
Non Current Liabilities Total57.1 M81 M
Way Down
Slightly volatile
Total Assets173.1 M167.5 M
Sufficiently Up
Slightly volatile
Total Current Assets156.5 M117 M
Significantly Up
Slightly volatile

Fortress Biotech F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Fortress Biotech's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Fortress Biotech in a much-optimized way.

About Fortress Biotech Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

2.64

At this time, Fortress Biotech's Book Value Per Share is very stable compared to the past year.

Fortress Biotech Current Valuation Drivers

We derive many important indicators used in calculating different scores of Fortress Biotech from analyzing Fortress Biotech's financial statements. These drivers represent accounts that assess Fortress Biotech's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fortress Biotech's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap140.6M228.3M204.3M58.7M24.4M23.2M
Enterprise Value118.9M84.0M(26.5M)7.7M32.1M53.6M

About Fortress Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Fortress Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fortress Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fortress Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Fortress Stock

When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:
Check out Fortress Biotech Altman Z Score, Fortress Biotech Correlation, Fortress Biotech Valuation, as well as analyze Fortress Biotech Alpha and Beta and Fortress Biotech Hype Analysis.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.03)
Revenue Per Share
7.954
Quarterly Revenue Growth
0.048
Return On Assets
(0.34)
Return On Equity
(17.40)
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.